Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Psoriasis × Anti-Infective Agents, Local × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Psoriasis 1 Lymphoma, Follicular 1

Interventions

tofacitinib 7 Etanercept 3 Adalimumab 2 secukinumab 1 apremilast 1 Methotrexate 1 Anti-Infective Agents, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01313221 2017-03-15

REFINE

Amgen

Phase 3 Completed

310 enrolled 32 charts

Lymphoma, Follicular, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡